Crossref journal-article
Wiley
Journal of Genetic Counseling (311)
Abstract

AbstractThe purpose of this paper is to report the outcome of a collaborative project between the Fragile X Research and Treatment Center at the Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute at the University of California at Davis, the National Fragile X Foundation (NFXF), and the Centers for Disease Control and Prevention (CDC). The objective of this collaboration was to develop and disseminate protocols for genetic counseling and cascade testing for the multiple disorders associated with the fragile X mental retardation 1 (FMR1) mutation. Over the last several years, there has been increasing insight into the phenotypic range associated with both the premutation and the full mutation of the FMR1 gene. To help develop recommendations related to screening for fragile X‐associated disorders, four, two day advisory focus group meetings were conducted, each with a different theme. The four themes were: (1) fragile X‐associated tremor/ataxia syndrome (FXTAS); (2) premature ovarian failure (POF) and reproductive endocrinology; (3) psychiatric, behavioral and psychological issues; and (4) population screening and related ethical issues.

Bibliography

McConkie‐Rosell, A., Abrams, L., Finucane, B., Cronister, A., Gane, L. W., Coffey, S. M., Sherman, S., Nelson, L. M., Berry‐Kravis, E., Hessl, D., Chiu, S., Street, N., Vatave, A., & Hagerman, R. J. (2007). Recommendations from Multi‐disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X‐associated Disorders. Journal of Genetic Counseling, 16(5), 593–606. Portico.

Authors 14
  1. Allyn McConkie‐Rosell (first)
  2. Liane Abrams (additional)
  3. Brenda Finucane (additional)
  4. Amy Cronister (additional)
  5. Louise W. Gane (additional)
  6. Sarah M. Coffey (additional)
  7. Stephanie Sherman (additional)
  8. Lawrence M. Nelson (additional)
  9. Elizabeth Berry‐Kravis (additional)
  10. David Hessl (additional)
  11. Sufen Chiu (additional)
  12. Natalie Street (additional)
  13. Ajay Vatave (additional)
  14. Randi J. Hagerman (additional)
References 64 Referenced 61
  1. 10.1007/s10897-006-9049-0
  2. 10.1007/s10897-005-1159-6
  3. 10.1002/ajmg.b.20030
  4. 10.4088/JCP.v67n0112
  5. 10.1002/ana.20360
  6. {'issue': '10', 'key': 'e_1_2_7_7_1', 'first-page': '1757', 'article-title': 'Fragile X premutation carriers: Characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction', 'volume': '23', 'author': 'Brunberg J. A.', 'year': '2002', 'journal-title': 'American Journal of Neuroradiology'} / American Journal of Neuroradiology / Fragile X premutation carriers: Characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction by Brunberg J. A. (2002)
  7. {'key': 'e_1_2_7_8_1', 'volume-title': 'Comorbidities in genetic syndromes.', 'author': 'Chiu S.', 'year': '2007'} / Comorbidities in genetic syndromes. by Chiu S. (2007)
  8. 10.1016/j.bandc.2004.08.020
  9. 10.1002/ajmg.10427
  10. {'issue': '5', 'key': 'e_1_2_7_11_1', 'first-page': '1025', 'article-title': 'Mental status of females with an FMR1 gene full mutation', 'volume': '58', 'author': 'Vries B. B.', 'year': '1996', 'journal-title': 'American Journal of Medical Genetics'} / American Journal of Medical Genetics / Mental status of females with an FMR1 gene full mutation by Vries B. B. (1996)
  11. 10.1093/hmg/11.4.371
  12. 10.1097/01.gim.0000200158.66554.7f
  13. 10.1097/00004703-200604002-00012
  14. 10.1016/S0165-1781(98)00055-9
  15. 10.1542/peds.91.2.321
  16. 10.1001/archpsyc.1992.01820010054007
  17. 10.1097/00004703-200412000-00002
  18. 10.56021/9780801868436 / Fragile X syndrome: Diagnosis, treatment and research by Hagerman R. J. (2002)
  19. 10.1086/386296
  20. 10.1002/mrdd.20005
  21. 10.1002/(SICI)1096-8628(19990402)83:4<313::AID-AJMG15>3.0.CO;2-F
  22. 10.1086/420700
  23. 10.1212/WNL.57.1.127
  24. 10.1212/01.wnl.0000168900.86323.9c
  25. 10.1159/000091656
  26. 10.1002/ajmg.a.31286
  27. 10.1002/ajmg.b.30241
  28. 10.1093/humrep/16.3.457
  29. 10.1086/374321
  30. 10.1001/jama.291.4.460
  31. 10.1136/jmg.2006.042374
  32. 10.1002/ajmg.1561
  33. 10.1093/brain/awh535
  34. 10.1002/ajmg.a.30229
  35. 10.1002/ajmg.1320430111
  36. 10.1002/mrdd.1410010411
  37. 10.1002/mrdd.20006
  38. 10.1097/00125817-200105000-00010
  39. 10.1023/A:1025857422026
  40. 10.1007/s10897-005-4802-x
  41. 10.1002/(SICI)1096-8628(19970110)68:1<62::AID-AJMG12>3.0.CO;2-M
  42. 10.1002/1096-8628(20000619)92:5<336::AID-AJMG8>3.0.CO;2-L
  43. 10.1002/ajmg.10396
  44. 10.1136/jmg.34.1.1
  45. 10.1177/096914139700400204
  46. 10.1093/humrep/14.5.1217
  47. 10.1086/367713
  48. 10.1017/S0954579403000464
  49. {'issue': '5', 'key': 'e_1_2_7_50_1', 'first-page': '884', 'article-title': 'Neurobehavioral effects of the fragile X premutation in adult women: A controlled study', 'volume': '52', 'author': 'Reiss A. L.', 'year': '1993', 'journal-title': 'American Journal of Human Genetics'} / American Journal of Human Genetics / Neurobehavioral effects of the fragile X premutation in adult women: A controlled study by Reiss A. L. (1993)
  50. 10.1002/ajmg.a.31165
  51. {'issue': '5', 'key': 'e_1_2_7_52_1', 'first-page': '1006', 'article-title': 'Prevalence of carriers of premutation‐size alleles of the FMRI gene—And implications for the population genetics of the fragile X syndrome', 'volume': '57', 'author': 'Rousseau F.', 'year': '1995', 'journal-title': 'American Journal of Human Genetics'} / American Journal of Human Genetics / Prevalence of carriers of premutation‐size alleles of the FMRI gene—And implications for the population genetics of the fragile X syndrome by Rousseau F. (1995)
  52. 10.1097/01.GIM.0000182468.22666.dd
  53. {'key': 'e_1_2_7_54_1', 'first-page': '332', 'volume-title': 'Fragile X syndrome: Diagnosis, treatment, and research', 'author': 'Sobesky W. E.', 'year': '1996'} / Fragile X syndrome: Diagnosis, treatment, and research by Sobesky W. E. (1996)
  54. 10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.0.CO;2-E
  55. 10.1093/humrep/deh635
  56. 10.1002/(SICI)1096-8628(19990528)84:3<240::AID-AJMG15>3.0.CO;2-B
  57. 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4
  58. 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V
  59. 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G
  60. 10.1016/j.bbr.2005.03.007
  61. 10.1038/sj.ejhg.5201312
  62. 10.1210/jc.2004-0347
  63. 10.1016/j.fertnstert.2006.09.004
  64. 10.1007/s00415-004-0558-1
Dates
Type When
Created 18 years, 3 months ago (May 11, 2007, 12:11 p.m.)
Deposited 1 year, 11 months ago (Sept. 14, 2023, 11:45 p.m.)
Indexed 1 month, 3 weeks ago (July 11, 2025, 6:25 a.m.)
Issued 18 years, 3 months ago (May 12, 2007)
Published 18 years, 3 months ago (May 12, 2007)
Published Online 18 years, 3 months ago (May 12, 2007)
Published Print 17 years, 11 months ago (Oct. 1, 2007)
Funders 0

None

@article{McConkie_Rosell_2007, title={Recommendations from Multi‐disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X‐associated Disorders}, volume={16}, ISSN={1573-3599}, url={http://dx.doi.org/10.1007/s10897-007-9099-y}, DOI={10.1007/s10897-007-9099-y}, number={5}, journal={Journal of Genetic Counseling}, publisher={Wiley}, author={McConkie‐Rosell, Allyn and Abrams, Liane and Finucane, Brenda and Cronister, Amy and Gane, Louise W. and Coffey, Sarah M. and Sherman, Stephanie and Nelson, Lawrence M. and Berry‐Kravis, Elizabeth and Hessl, David and Chiu, Sufen and Street, Natalie and Vatave, Ajay and Hagerman, Randi J.}, year={2007}, month=may, pages={593–606} }